Annals ofRheumatoid Arthritis

Volume: 1 - Number: 3 - September 15, 2003

Outstanding

Current Consensus Recommendations for Rheumatoid Arthritis Therapy: A Blind Spot for Osteoporosis Prevention and Treatment

Cases of Early Inflammatory Polyarthritis Should Not Be Classified as Having Rheumatoid Arthritis

Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate A Randomized, Double-Blind, Placebo-Controlled Trial

Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis

Cases Reports

Case 5-2003 — A 16-Year-Old Girl with a Rash and Chest Pain

Case 29-2002 — A 17-Year-Old Boy with Acute Mitral Regurgitation and Pulmonary Edema

Case 39-2002 — A 35-Year-Old Man with Headache, Deviation of the Tongue, and Unusual Radiographic Abnormalities

Case 23-2002 — A 73-Year-Old Man with Leg Pains, Occipital Headaches, and Night Sweats

Case 30-2002 — An Eight-Year-Old Girl with Fever, Hemoptysis, and Pulmonary Consolidations

Case 21-2002 — A 21-Year-Old Man with Arthritis during Treatment for Hyperthyroidism

Case 2-2003 — A 60-Year-Old Man with Mild Congestive Heart Failure of Uncertain Cause

Case 21-2003 — A 72-Year-Old Man with Repetitive Strokes in the Posterior Circulation

Case 18-2001— A 19-Month-Old Boy with Fever and Soft-Tissue Masses

Contribution's and Articles

Cytokines and cellular interactions in inflammatory synovitis

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

C-reactive protein: a critical update

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

Corticotropin-releasing hormone regulates IL-6 expression during inflammation

Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate A Randomized, Double-Blind, Placebo-Controlled Trial

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

Citrulline is an Essential Constituent of Antigenic Determinants Recognized by Rheumatoid Arthritis-specific Autoantibodies

Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity

Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

Editorial

Current Consensus Recommendations for Rheumatoid Arthritis Therapy: A Blind Spot for Osteoporosis Prevention and Treatment

COX 2 inhibitors may increase risk of heart attack?

Crawling Through the Web: What Do Our Patients Find?

Commentary: Do genes or environment influence development of rheumatoid arthritis?

Clinical Evaluation Versus Ultrasonography: Who Is the Winner?

Cases of Early Inflammatory Polyarthritis Should Not Be Classified as Having Rheumatoid Arthritis